ZA200905691B - Improved medicinal compositions comprising buprenorphine and naloxone - Google Patents

Improved medicinal compositions comprising buprenorphine and naloxone

Info

Publication number
ZA200905691B
ZA200905691B ZA200905691A ZA200905691A ZA200905691B ZA 200905691 B ZA200905691 B ZA 200905691B ZA 200905691 A ZA200905691 A ZA 200905691A ZA 200905691 A ZA200905691 A ZA 200905691A ZA 200905691 B ZA200905691 B ZA 200905691B
Authority
ZA
South Africa
Prior art keywords
naloxone
buprenorphine
medicinal compositions
improved medicinal
improved
Prior art date
Application number
ZA200905691A
Other languages
English (en)
Inventor
Christopher Bourne Chapleo
Neil Hyde
Original Assignee
Uk Reckitt Benckiser Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uk Reckitt Benckiser Healthcare Ltd filed Critical Uk Reckitt Benckiser Healthcare Ltd
Publication of ZA200905691B publication Critical patent/ZA200905691B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200905691A 2007-03-01 2009-08-17 Improved medicinal compositions comprising buprenorphine and naloxone ZA200905691B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0703967A GB2447015A (en) 2007-03-01 2007-03-01 Analgesic composition comprising a specific ratio of buprenorphine and naltrexone

Publications (1)

Publication Number Publication Date
ZA200905691B true ZA200905691B (en) 2010-10-27

Family

ID=37965734

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200905691A ZA200905691B (en) 2007-03-01 2009-08-17 Improved medicinal compositions comprising buprenorphine and naloxone

Country Status (16)

Country Link
US (1) US20100168147A1 (xx)
EP (1) EP2114453A1 (xx)
JP (1) JP2010520185A (xx)
KR (1) KR20090115863A (xx)
CN (2) CN101622013A (xx)
AR (1) AR065581A1 (xx)
AU (1) AU2008220573A1 (xx)
BR (1) BRPI0807905A2 (xx)
CA (1) CA2678675A1 (xx)
CL (1) CL2008000610A1 (xx)
GB (1) GB2447015A (xx)
MX (1) MX2009009133A (xx)
PE (1) PE20081874A1 (xx)
TW (1) TW200836738A (xx)
WO (1) WO2008104737A1 (xx)
ZA (1) ZA200905691B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2054031T1 (sl) 2006-07-21 2016-09-30 Biodelivery Sciences International, Inc. Transmukozne naprave za administracijo z izboljšanim vnosom
ES2663777T3 (es) * 2008-06-23 2018-04-17 Biodelivery Sciences International, Inc. Dispositivos de administración mucosa multidireccionales y métodos de uso
US8475832B2 (en) * 2009-08-07 2013-07-02 Rb Pharmaceuticals Limited Sublingual and buccal film compositions
WO2013026064A1 (en) 2011-08-18 2013-02-21 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
PT2706986E (pt) 2011-09-19 2015-07-07 Orexo Ab Nova composição farmacêutica resistente ao abuso para o tratamento da dependência de opiáceos
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US20140275148A1 (en) * 2013-03-15 2014-09-18 Novus Pharma LLC Orally administrable, self-supporting dissolving film dosage forms
EP3082816B1 (en) 2013-12-20 2019-03-20 Indivior UK Limited Intranasal naloxone compositions and methods of making and using same
US10085937B2 (en) 2014-03-14 2018-10-02 Adapt Pharma Limited Nasal drug products and methods of their use
SG10202003562WA (en) 2014-03-14 2020-05-28 Opiant Pharmaceuticals Inc Nasal drug products and methods of their use
US9561177B2 (en) 2014-03-14 2017-02-07 Adapt Pharma Limited Nasal drug products and methods of their use
US9480644B2 (en) 2014-03-14 2016-11-01 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4457933A (en) * 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
GB8332556D0 (en) * 1983-12-06 1984-01-11 Reckitt & Colmann Prod Ltd Analgesic compositions
BR9813826A (pt) * 1997-12-22 2000-10-10 Euro Celtique Sa Potencial de uso abusivo de administração oral de opióide analgésico
AR031682A1 (es) * 1999-11-19 2003-10-01 Reckitt Benckiser Helthcare Uk Composiciones farmaceuticas
US20050191340A1 (en) * 2002-08-09 2005-09-01 Gruenenthal Gmbh Opioid-receptor antagonists in transdermal systems having buprenorphine
AU2003283055A1 (en) * 2002-08-09 2004-02-25 Grunenthal Gmbh Opioid-receptor antagonists in transdermal systems having buprenorphine
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
WO2008109779A2 (en) * 2007-03-07 2008-09-12 The Johns Hopkins University Use of follistatin-like related gene (flrg) to increase muscle mass

Also Published As

Publication number Publication date
PE20081874A1 (es) 2009-01-26
US20100168147A1 (en) 2010-07-01
CA2678675A1 (en) 2008-09-04
CN102670610A (zh) 2012-09-19
GB2447015A (en) 2008-09-03
AU2008220573A1 (en) 2008-09-04
BRPI0807905A2 (pt) 2014-06-17
KR20090115863A (ko) 2009-11-09
WO2008104737A1 (en) 2008-09-04
EP2114453A1 (en) 2009-11-11
TW200836738A (en) 2008-09-16
AR065581A1 (es) 2009-06-17
CN101622013A (zh) 2010-01-06
MX2009009133A (es) 2009-09-03
CL2008000610A1 (es) 2008-09-05
JP2010520185A (ja) 2010-06-10
GB0703967D0 (en) 2007-04-11

Similar Documents

Publication Publication Date Title
HRP20182124T1 (hr) Farmaceutski sastavi s trenutnim oslobađanjem koji sadrže oksikodon i nalokson
HK1256805A1 (zh) 藥物組合物和其給藥
ZA200905689B (en) Improved medicinal compositions comprising buprenorphine and naltrexone
ZA200905691B (en) Improved medicinal compositions comprising buprenorphine and naloxone
IL242883B (en) Aryl-amino and heteroaryl-amino converted deoxazolines and pharmaceutical preparations containing them
ZA201203709B (en) Immunogenic compositions and methods
EP2262367A4 (en) PHARMACEUTICAL ORAL COMPOSITIONS OF BUPRENORPHINE AND METHOD FOR THEIR USE
SI2224917T1 (sl) Sestavek, ki obsega nikotin in opipramol ter njegova uporaba
AP3441A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
ZA200807614B (en) Buprenorphine derivatives and uses thereof
HK1139868A1 (en) Improved medicinal compositions comprising buprenorphine and nalmefene
GB0906046D0 (en) Nalmefene compositions and their therapeutic use
GB0906045D0 (en) Nalmefene compositions and their therapeutic use
GB0906044D0 (en) Nalmefene compositions and their therapeutic use
GB0906043D0 (en) Nalmefene compositions and their therapeutic use
GB0906042D0 (en) Nalmefene compositions and their therapeutic use